| Inhibition of the endoribonuclease of ERN1 signaling enzyme affects the expression of proliferation-related genes in U87 glioma cells OH Minchenko, DO Tsymbal, M Moenner, DO Minchenko, OV Kovalevska, ... Endoplasm Reticul Stress Dis 2, 18-29, 2015 | 42* | 2015 |
| Inhibition of ERN1 modifies the hypoxic regulation of the expression of TP53-related genes in U87 glioma cells DO Minchenko, SV Danilovskyi, IV Kryvdiuk, TV Bakalets, NM Lypova, ... Cell Pathology 1 (1), 18-26, 2014 | 37 | 2014 |
| Increased 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase-3 activity in response to EGFR signaling contributes to non–small cell lung cancer cell survival N Lypova, S Telang, J Chesney, Y Imbert-Fernandez Journal of Biological Chemistry 294 (27), 10530-10543, 2019 | 30 | 2019 |
| Targeting palbociclib-resistant estrogen receptor-positive breast cancer cells via oncolytic virotherapy N Lypova, L Lanceta, A Gipson, S Vega, R Garza-Morales, KM McMasters, ... Cancers 11 (5), 684, 2019 | 26 | 2019 |
| Molecular mechanisms of ERN1-mediated angiogenesis OH Minchenko, KI Kubaichuk, DO Minchenko, OV Kovalevska, ... International Journal of Physiology and Pathophysiology 5 (1), 2014 | 22 | 2014 |
| Transcriptomic profiling identifies differentially expressed genes in palbociclib-resistant ER+ MCF7 breast cancer cells L Lanceta, C O’Neill, N Lypova, X Li, E Rouchka, S Waigel, ... Genes 11 (4), 467, 2020 | 16 | 2020 |
| PFKFB3 inhibition impairs erlotinib-induced autophagy in NSCLCs N Lypova, SM Dougherty, L Lanceta, J Chesney, Y Imbert-Fernandez Cells 10 (7), 1679, 2021 | 13 | 2021 |
| 6-Phosphofructo-2-Kinase (PFKFB3): at the crossroads of resistance to targeted cancer therapies S Telang, J O'Neal, Y Imbert-Fernandez, B Clem, N Lypova, GH Tapolsky, ... Cancer Research 75 (15_Supplement), 4478-4478, 2015 | 8 | 2015 |
| Differential gene expression analysis of palbociclib-resistant TNBC via RNA-seq L Lanceta, N Lypova, C O’Neill, X Li, E Rouchka, J Chesney, ... Breast Cancer Research and Treatment 186, 677-686, 2021 | 7 | 2021 |
| Obtaining and analysis of tobacco, lettuce and rape plants transformed with human interferon alfa 2b gene IM Gerasymenko, NM Lypova, LA Sakhno, NL Shcherbak, ... Factors of experimental evolution of organisms 7, 274-9, 2009 | 7 | 2009 |
| 6-phosphofructo-2-kinase enhances cytotoxicity of the EGFR inhibitor erlotinib via regulation of cell cycle in non-small lung cancer cell lines N Lypova, L Lanceta, J Chesney, Y Imbert-Fernandez Cancer Research 81 (13_Supplement), 1052-1052, 2021 | 1 | 2021 |
| AggregAtion of plAtelets, proliferAtion of endotheliAl cells And motility of cAncer cells Are mediAted by the bβ1 (15)-42 residue of fibrin (ogen) YM StohNII, MV RYzhYkoVa, V ReBRIeV, MD Kuchma, RY Marunych, ... Ukrainian Biochemical Journal, 72-84, 2020 | 1 | 2020 |
| Expression of 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase-1 and-2 and its unique alternative splice variants in U87 glioma cells with ERN1 loss of function NM Lypova, DO Minchenko, KI Kubaichuk, OH Minchenko Физика живого 19 (1), 40-51, 2011 | 1 | 2011 |
| 6-Phosphofructo-2-kinase/fructose-2, 6-bisphosphatase genus: structural organization, expression and regulation of the expression DO Minchenko, AY Bobarykina, AB Kundieva, NM Lypova, IV Bozhko, ... Біологічні студії/Studia Biologica 3 (3), 123-140, 2009 | 1 | 2009 |
| Role of 6-Phosphofructo-2-Kinase/Fructose-2, 6-Bisphosphatase-3 in Maintaining Redox Homeostasis and DNA Repair in Non-Small Cell Lung Cancers Under EGFR-Targeting Therapy N Lypova, SM Dougherty, BF Clem, J Feng, X Yin, X Zhang, X Li, ... bioRxiv, 2024.03. 25.586703, 2024 | | 2024 |
| 6-Phosphofructo-2-kinase in regulating DNA damage and repair in EGFR-driven lung cancer N Lypova, L Lanceta, S Dougherty, J Chesney, Y Imbert-Fernandez Cancer Research 83 (7_Supplement), 6202-6202, 2023 | | 2023 |
| Abstract P1-13-18: EGFR signaling contributes to acquired resistance to CDK4/6 inhibitors in ER+ breast cancer cells in vitro and in vivo N Lypova, L Lanceta, S Daugherty, J Chesney, Y Imbert-Fernandez Cancer Research 83 (5_Supplement), P1-13-18-P1-13-18, 2023 | | 2023 |
| EGFR signaling as a mechanism of resistance to CDK4/6 inhibitors in Palbociclib-resistant ER+ breast cancer cells N Lypova, L Lanceta, SM Dougherty, JA Chesney, Y Imbert-Fernandez Cancer Research 82 (12_Supplement), 1772-1772, 2022 | | 2022 |
| 6-Phosphofructo-2-kinase inhibition to increase the efficacy of ER and CDK4/6 inhibitors against ER+ breast cancer L Lanceta, N Lypova, J Chesney, Y Imbert-Fernandez Cancer Research 80 (16_Supplement), 6001-6001, 2020 | | 2020 |
| Expression of key circadian genes as well as protein kinase NUAK2 as sensitive markers of in vivo toxic action of methyl tertial butyl ether DOM Oleksandr H.Minchenko, Oleksandr P.Yavorovsky, Yuriy O.Paustovsky, Nadia ... Applied Cell Biology 3 (4), 129-138, 2014 | | 2014 |
Oleksandr MinchenkoPalladin Institute of BiochemistryVerified email at biochem.kiev.ua
